Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Session Type:

Availability:

  • Sort by:
  • Browse by:
<< first | < prev page: of 2 records per page: next > | last >>
pages: 1 2 presentations: 1 to 50 of 95 from CROI 2019
WEDNESDAY PLENARY SESSION
RAISING THE WALL IN MATERNAL/FETAL IMMUNITY   (ABSTRACT 67)
Sallie Permar
Duke Human Vaccine Institute, Durham, NC, USA
from CROI 2019 on March 6, 2019 8:30 AM-9:30 AM
WEDNESDAY PLENARY SESSION
HUGGING PHYLOGENETIC TREES: USE OF MOLECULAR ANALYSIS FOR PUBLIC HEALTH INTERVENTION   (ABSTRACT 68)
Alexandra M. Oster
CDC, Atlanta, GA, USA
from CROI 2019 on March 6, 2019 8:30 AM-9:30 AM
ORAL ABSTRACT: HEPATITIS C: NOW YOU SEE ME; SOON YOU WON'T
FALL IN HCV INCIDENCE IN HIV+ MSM IN LONDON FOLLOWING WIDER ACCESS TO DAA THERAPY   (ABSTRACT 85)
Lucy Jane Garvey
Imperial College Healthcare NHS Trust, London, United Kingdom
from CROI 2019 on March 6, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: HEPATITIS C: NOW YOU SEE ME; SOON YOU WON'T
HCV REINFECTION AMONG HIV-INFECTED MSM IN NEW YORK CITY   (ABSTRACT 86)
Daniel S. Fierer
Icahn School of Medicine at Mount Sinai, New York, NY, USA
from CROI 2019 on March 6, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: HEPATITIS C: NOW YOU SEE ME; SOON YOU WON'T
A PHASE 1 STUDY OF LEDIPASVIR/SOFOSBUVIR IN PREGNANT WOMEN WITH HEPATITIS C VIRUS   (ABSTRACT 87)
Catherine Anne Chappell
Magee-Womens Hospital of UPMC, Pittsburgh, PA, USA
from CROI 2019 on March 6, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: HEPATITIS C: NOW YOU SEE ME; SOON YOU WON'T
INCIDENT DIABETES AND GLUCOSE CONTROL AFTER HCV TREATMENT WITH DAAS IN ERCHIVES   (ABSTRACT 88)
Adeel Ajwad Butt
Weill Cornell Medical College, New York, NY, USA
from CROI 2019 on March 6, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: HEPATITIS C: NOW YOU SEE ME; SOON YOU WON'T
INTRAHEPATIC HEPATITIS C KINETICS WITH DIRECT-ACTING ANTIVIRALS IN HIV COINFECTION   (ABSTRACT 89)
Ashwin Balagopal
Johns Hopkins University, Baltimore, MD, USA
from CROI 2019 on March 6, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: HEPATITIS C: NOW YOU SEE ME; SOON YOU WON'T
HIV VIREMIA AND LOW CD4+ INCREASE HCC RISK IN THOSE WITHOUT ADVANCED LIVER FIBROSIS   (ABSTRACT 90)
Jessie Torgersen
University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
from CROI 2019 on March 6, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: HEPATITIS C: NOW YOU SEE ME; SOON YOU WON'T
SINGLE HEPATOCYTE ANALYSIS IN HIV-HBV COINFECTION SHOWS HBV TRANSCRIPTION SILENCING   (ABSTRACT 91)
Chloe Thio
Johns Hopkins University School of Medicine, Baltimore, MD, USA
from CROI 2019 on March 6, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: NEW OPTIONS AND OPPORTUNITIES IN PrEP
PROTECTION AGAINST PENILE OR INTRAVENOUS SHIV CHALLENGES BY BNAB 10-1074 OR 3BNC117   (ABSTRACT 100)
David A Garber
Centers for Disease Control and Prevention, Atlanta, GA, USA
from CROI 2019 on March 6, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: NEW OPTIONS AND OPPORTUNITIES IN PrEP
PROTECTION AGAINST VAGINAL SHIV INFECTION WITH AN INSERT CONTAINING TAF AND EVG   (ABSTRACT 101)
Charles Dobard
CDC, Atlanta, GA, USA
from CROI 2019 on March 6, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: NEW OPTIONS AND OPPORTUNITIES IN PrEP
MODERATE EFFICACY OF ORAL SINGLE-AGENT TAF AGAINST VAGINAL SHIV INFECTION IN MACAQUES   (ABSTRACT 102)
Ivana Massud
Centres for Disease Control and Prevention, Atlanta, GA, USA
from CROI 2019 on March 6, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: NEW OPTIONS AND OPPORTUNITIES IN PrEP
LYMPHOID TISSUE PHARMACOKINETICS OF TENOFOVIR-ALAFENAMIDE VS -DISOPROXIL FUMARATE   (ABSTRACT 103)
Courtney V. Fletcher
University of Nebraska Medical Center, Omaha, NE, USA
from CROI 2019 on March 6, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: NEW OPTIONS AND OPPORTUNITIES IN PrEP
THE PHASE 3 DISCOVER STUDY: DAILY F/TAF OR F/TDF FOR HIV PREEXPOSURE PROPHYLAXIS   (ABSTRACT 104)
Charles B Hare
Kaiser Permanente San Francisco Medical Center, San Francisco, CA, USA
from CROI 2019 on March 6, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: NEW OPTIONS AND OPPORTUNITIES IN PrEP
USING EHR DATA TO IDENTIFY POTENTIAL PREP CANDIDATES IN A LARGE HEALTH CARE SYSTEM   (ABSTRACT 105)
Julia L. Marcus
Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA
from CROI 2019 on March 6, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: NEW OPTIONS AND OPPORTUNITIES IN PrEP
PERSISTENCE WITH HIV PREEXPOSURE PROPHYLAXIS IN THE UNITED STATES, 2012-2016   (ABSTRACT 106)
Ya-Lin A Huang
Centers for Disease Control and Prevention, Atlanta, GA, USA
from CROI 2019 on March 6, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: NEW OPTIONS AND OPPORTUNITIES IN PrEP
IMPACT OF PREP ON DRUG RESISTANCE AND ACUTE HIV INFECTION, NEW YORK CITY, 2015-2017   (ABSTRACT 107)
Kavita Misra
New York City Department of Health and Mental Hygiene, Long Island City, NY, USA
from CROI 2019 on March 6, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: TB: FROM CONTACT TO CURE AND BEYOND
IPT AND PREGNANCY OUTCOMES IN HIV-POSITIVE WOMEN: THE TSHEPISO COHORT   (ABSTRACT 77)
Nicole Salazar-Austin
Johns Hopkins University School of Medicine, Baltimore, MD, USA
from CROI 2019 on March 6, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: TB: FROM CONTACT TO CURE AND BEYOND
POTENTIAL CONCERN FOR TIMING OF DMPA INJECTION AMONG WOMEN TREATED FOR HIV AND TB   (ABSTRACT 78)
Rosie Mngqibisa
Enhancing Care Initiative, Durban RSA, South Africa
from CROI 2019 on March 6, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: TB: FROM CONTACT TO CURE AND BEYOND
IMPROVING CHILD TUBERCULOSIS CONTACT MANAGEMENT IN LESOTHO   (ABSTRACT 79)
Yael Hirsch-Moverman
Columbia University, Mailman School of Public Health, New York, NY, USA
from CROI 2019 on March 6, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: TB: FROM CONTACT TO CURE AND BEYOND
SAFETY & PK OF WEEKLY RIFAPENTINE/ISONIAZID (3HP) IN ADULTS WITH HIV ON DOLUTEGRAVIR   (ABSTRACT 80)
Kelly E Dooley
Johns Hopkins University, Baltimore, MD, USA
from CROI 2019 on March 6, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: TB: FROM CONTACT TO CURE AND BEYOND
PHARMACOKINETICS AND SAFETY OF ADJUSTED DARUNAVIR/RITONAVIR WITH RIFAMPIN IN PLWH   (ABSTRACT 81)
Gary Maartens
University of Cape Town, Cape Town, South Africa
from CROI 2019 on March 6, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: TB: FROM CONTACT TO CURE AND BEYOND
EARLY BACTERICIDAL ACTIVITY OF HIGH-DOSE ISONIAZID AGAINST MULTIDRUG-RESISTANT TB   (ABSTRACT 82)
Kelly E Dooley
Johns Hopkins University, Baltimore, MD, USA
from CROI 2019 on March 6, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: TB: FROM CONTACT TO CURE AND BEYOND
LONG-TERM MORTALITY AFTER TUBERCULOSIS CURE IN THE CIPRA HT-001 TRIAL   (ABSTRACT 83)
Yvetot Joseph
Les Centres GHESKIO, Haiti, Port-au-Prince, Haiti
from CROI 2019 on March 6, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: TB: FROM CONTACT TO CURE AND BEYOND
QT EFFECTS OF BEDAQUILINE, DELAMANID OR BOTH IN MDR-TB PATIENTS: THE DELIBERATE TRIAL   (ABSTRACT 84)
Gary Maartens
University of Cape Town, Cape Town, South Africa
from CROI 2019 on March 6, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: TESTING, VIRAL SUPPRESSION, AND IMPACT
IMPACT OF UNIVERSAL TESTING AND TREATMENT IN ZAMBIA AND SOUTH AFRICA: HPTN071(POPART)   (ABSTRACT 92)
Richard J Hayes
London School of Hygiene and Tropical Medicine, London, United Kingdom
from CROI 2019 on March 6, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: TESTING, VIRAL SUPPRESSION, AND IMPACT
A RANDOMIZED TRIAL ON INDEX HIV SELF-TESTING FOR PARTNERS OF ART CLIENTS IN MALAWI   (ABSTRACT 93)
Kathryn Dovel
University of California Los Angeles, Westwood, CA, USA
from CROI 2019 on March 6, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: TESTING, VIRAL SUPPRESSION, AND IMPACT
VIRAL LOAD SUPPRESSION AND YIELD OF HIV TESTS ARE SPATIALLY CORRELATED, KENYA 2015-17   (ABSTRACT 94)
Anthony Waruru
U.S. Centers for Disease Control and Prevention, Nairobi, Kenya
from CROI 2019 on March 6, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: TESTING, VIRAL SUPPRESSION, AND IMPACT
HIV TESTING, TREATMENT, AND VIRAL SUPPRESSION COVERAGE IN A CLUSTER-RANDOMIZED TRIAL   (ABSTRACT 95)
Kathleen Wirth
Harvard T.H. Chan School of Public Health, Boston, MA, USA
from CROI 2019 on March 6, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: TESTING, VIRAL SUPPRESSION, AND IMPACT
FACTORS ASSOCIATED WITH PERSISTENT VIREMIA WITH UNIVERSAL “TEST & TREAT” IN UGANDA   (ABSTRACT 96)
Eshan Uday Patel
Johns Hopkins University, Baltimore, MD, USA
from CROI 2019 on March 6, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: TESTING, VIRAL SUPPRESSION, AND IMPACT
VIROLOGIC FAILURE, LOW-LEVEL VIREMIA, AND VIRAL BLIP AFTER HIV RNA SUPPRESSION   (ABSTRACT 97)
Jennifer S Lee
Johns Hopkins University, Baltimore, MD, USA
from CROI 2019 on March 6, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: TESTING, VIRAL SUPPRESSION, AND IMPACT
FIFTY-PERCENT REDUCTION IN HIV INCIDENCE IN CHOKWE DISTRICT, MOZAMBIQUE, 2014-2017   (ABSTRACT 98)
Duncan Alan MacKellar
CDC, Lilburn, GA, USA
from CROI 2019 on March 6, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: TESTING, VIRAL SUPPRESSION, AND IMPACT
A MODEL IMPACT ANALYSIS OF PREP AND TASP IN FSW DEMONSTRATION PROJECT IN BENIN   (ABSTRACT 99)
Lily Geidelberg
Imperial College London, London, UT, United Kingdom
from CROI 2019 on March 6, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: VIRUS-CELL INTERACTION
ORAL ABSTRACT MODERATOR
Stefan Sarafianos
Emory University School of Medicine, Atlanta, GA, USA
from CROI 2019 on March 6, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: VIRUS-CELL INTERACTION
A VIRUS-PACKAGEABLE CRISPR SCREEN IDENTIFIES HIV RESTRICTION AND DEPENDENCY FACTORS   (ABSTRACT 69)
Molly Ohainle
Fred Hutchinson Cancer Research Center, Seattle, WA, USA
from CROI 2019 on March 6, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: VIRUS-CELL INTERACTION
A FUNCTIONAL MAP OF HIV-HOST INTERACTIONS IN PRIMARY HUMAN CD4+ T CELLS   (ABSTRACT 70)
Judd F Hultquist
Northwestern University, Chicago, IL, USA
from CROI 2019 on March 6, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: VIRUS-CELL INTERACTION
HIV-1 COMPLEXES TRAFFIC WITH HOST CPSF6 ON MICROTUBULES PRIOR TO NUCLEAR ENTRY   (ABSTRACT 71)
Zandrea Ambrose
University of Pittsburgh, Pittsburgh, PA, USA
from CROI 2019 on March 6, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: VIRUS-CELL INTERACTION
HIV-1 CAPSID DETERMINANTS THAT INFLUENCE NUCLEAR ENVELOPE DOCKING AND NUCLEAR IMPORT   (ABSTRACT 72)
Mohamed Husen Munshi
National Cancer Institute, Frederick, MD, USA
from CROI 2019 on March 6, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: VIRUS-CELL INTERACTION
SINGLE HIV-1 VIRUS IMAGING WITH CA-EGFP QUESTIONS A ROLE OF NUCLEAR CA IN INTEGRATION   (ABSTRACT 73)
Frauke Christ
Katholieke University Leuven, Leuven, Belgium
from CROI 2019 on March 6, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: VIRUS-CELL INTERACTION
DISRUPTION OF HIV-1 LTR SEQUENCE BY A NUCLEOCAPSID MUTATION LEADS TO DTG RESISTANCE   (ABSTRACT 74)
Atsuko Hachiya
National Hospital Organization Nagoya Medical Center, Aichi, Japan
from CROI 2019 on March 6, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: VIRUS-CELL INTERACTION
INTEGRASE (IN) TETRAMERS ARE THE AUTHENTIC TARGETS FOR ALLOSTERIC HIV-1 IN INHIBITORS   (ABSTRACT 75)
Pratibha Chowdary Koneru
University of Colorado, Aurora, CO, USA
from CROI 2019 on March 6, 2019 10:00 AM-12:00 PM
ORAL ABSTRACT: VIRUS-CELL INTERACTION
TARGETING VIRUS ENV AND CD44 IMPROVES BBAB AVIDITY AND NEUTRALIZATION POTENCY   (ABSTRACT 76)
Djin-Ye Oh
Aaron Diamond AIDS Research Center, New York, NY, USA
from CROI 2019 on March 6, 2019 10:00 AM-12:00 PM
THEMED DISCUSSION: EARLY EVENTS
THEMED DISCUSSION LEADER
Michael Emerman
Fred Hutchinson Cancer Research Center, Seattle, WA, USA
from CROI 2019 on March 6, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: EARLY EVENTS
ENTRY KINETICS OF GLOBALLY REPRESENTATIVE AND VERTICALLY TRANSMITTED HIV ENVELOPES   (ABSTRACT 166)
Nicholas E. Webb
University of California Los Angeles, Los Angeles, CA, USA
from CROI 2019 on March 6, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: EARLY EVENTS
CD4-DEPENDENT MODULATION OF HIV-1 ENTRY BY LY6E   (ABSTRACT 167)
Shan-Lu Liu
The Ohio State University, Columbus, OH, USA
from CROI 2019 on March 6, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: EARLY EVENTS
ELUCIDATING MECHANISMS BY WHICH MUTATIONS IN ENV CONTRIBUTE TO HIV-1 DRUG RESISTANCE   (ABSTRACT 168)
Rachel Van Duyne
National Cancer Institute, Frederick, MD, USA
from CROI 2019 on March 6, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: EARLY EVENTS
NONRANDOM GENERATION OF DELETIONS WITHIN HIV PROVIRAL SEQUENCES IN VIVO   (ABSTRACT 169)
Bonnie Hiener
The Westmead Institute for Medical Research, Westmead, Australia
from CROI 2019 on March 6, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: EARLY EVENTS
HOST FACTORS INFLUENCE SIV AND HIV-1 INFECTION AND SENSITIVITY TO CAPSID INHIBITORS   (ABSTRACT 170)
Carsten Münk
Heinrich-Heine-University Hospital, Düsseldorf, Germany
from CROI 2019 on March 6, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: EARLY EVENTS
QUESTIONS AND ANSWERS
from CROI 2019 on March 6, 2019 1:30 PM-2:30 PM
THEMED DISCUSSION: INSIGHT FROM ANALYTICAL TREATMENT INTERRUPTIONS
THEMED DISCUSSION LEADER
John Frater
University of Oxford, Oxford, United Kingdom
from CROI 2019 on March 6, 2019 1:30 PM-2:30 PM
<< first | < prev page: of 2 records per page: next > | last >>
pages: 1 2 presentations: 1 to 50 of 95 from CROI 2019